Drug-Drug Interactions With Oral Antineoplastic Agents
Authors:
- 1 June 2017
- journal article
- viewpoint
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 3 (6) , 736-738
Abstract
This Viewpoint addresses the increasing incidence of drug-drug interactions with personalized cancer treatment drugs.Keywords
This publication has 2 references indexed in Scilit:
- Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinibBlood, 2011
- Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugsTrends in Pharmacological Sciences, 2006